Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07630155 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 2027 → Dec 2027
See other at-risk trials from University of Michigan Rogel Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 2026 to Dec 2026
    • Primary and study completion pushed from Aug 2027 to Dec 2027
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 3 of 3 entries
  2. Recruitment opened
    • Primary and study completion pushed from Jul 2027 to Aug 2027
    • Start date: Jul 18, 2026 to Aug 2026
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial tests how well office based ureteroscopy utilizing a single use digital, flexible ureteroscope works for the assessment of upper tract urothelial carcinoma. Ureteroscopy is a procedure in which a thin camera called a ureteroscope is used to assess patients with a known or suspected diagnosis of upper tract urothelial carcinoma. Ureteroscopy is traditionally performed in an operating room under general anesthesia. In this study, patients undergo ureteroscopy in the doctor's office using an ultra-thin ureteroscope, which is the narrowest instrument of its kind. Because of its small size, researchers believe this procedure can be completed in the office with minimal discomfort and high patient satisfaction, which may eliminate the risks of general anesthesia and reduce delays to diagnosis. Office based ureteroscopy utilizing a single use digital, flexible ureteroscope may be effective for the assessment of upper tract urothelial carcinoma.
Trial Details
NCT Number NCT07630155
Lead Sponsor University of Michigan Rogel Cancer Center
Collaborators: Shenzhen HugeMed Medical Technical Development
Conditions
(from sponsor)		 Renal Pelvis and Ureter Urothelial Carcinoma
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov